Pathologic and molecular insights in nodal T-follicular helper cell lymphomas

T-follicular helper (TFH) cells are one of the T-cell subsets with a critical role in the regulation of germinal center (GC) reactions. TFH cells contribute to the positive selection of GC B-cells and promote plasma cell differentiation and antibody production. TFH cells express a unique phenotype c...

Full description

Bibliographic Details
Main Authors: Mario L. Marques-Piubelli, Catalina Amador, Francisco Vega
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1105651/full
_version_ 1811175346399084544
author Mario L. Marques-Piubelli
Catalina Amador
Francisco Vega
author_facet Mario L. Marques-Piubelli
Catalina Amador
Francisco Vega
author_sort Mario L. Marques-Piubelli
collection DOAJ
description T-follicular helper (TFH) cells are one of the T-cell subsets with a critical role in the regulation of germinal center (GC) reactions. TFH cells contribute to the positive selection of GC B-cells and promote plasma cell differentiation and antibody production. TFH cells express a unique phenotype characterized by PD-1hi, ICOShi, CD40Lhi, CD95hi, CTLAhi, CCR7lo, and CXCR5hi. Three main subtypes of nodal TFH lymphomas have been described: 1) angioimmunoblastic-type, 2) follicular-type, and 3) not otherwise specified (NOS). The diagnosis of these neoplasms can be challenging, and it is rendered based on a combination of clinical, laboratory, histopathologic, immunophenotypic, and molecular findings. The markers most frequently used to identify a TFH immunophenotype in paraffin-embedded tissue sections include PD-1, CXCL13, CXCR5, ICOS, BCL6, and CD10. These neoplasms feature a characteristic and similar, but not identical, mutational landscape with mutations in epigenetic modifiers (TET2, DNMT3A, IDH2), RHOA, and T-cell receptor signaling genes. Here, we briefly review the biology of TFH cells and present a summary of the current pathologic, molecular, and genetic features of nodal lymphomas. We want to highlight the importance of performing a consistent panel of TFH immunostains and mutational studies in TCLs to identify TFH lymphomas.
first_indexed 2024-04-10T19:34:33Z
format Article
id doaj.art-835398c8a6e542ec907280c5a6b38086
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T19:34:33Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-835398c8a6e542ec907280c5a6b380862023-01-30T08:50:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011310.3389/fonc.2023.11056511105651Pathologic and molecular insights in nodal T-follicular helper cell lymphomasMario L. Marques-Piubelli0Catalina Amador1Francisco Vega2Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesDivision of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, United StatesDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United StatesT-follicular helper (TFH) cells are one of the T-cell subsets with a critical role in the regulation of germinal center (GC) reactions. TFH cells contribute to the positive selection of GC B-cells and promote plasma cell differentiation and antibody production. TFH cells express a unique phenotype characterized by PD-1hi, ICOShi, CD40Lhi, CD95hi, CTLAhi, CCR7lo, and CXCR5hi. Three main subtypes of nodal TFH lymphomas have been described: 1) angioimmunoblastic-type, 2) follicular-type, and 3) not otherwise specified (NOS). The diagnosis of these neoplasms can be challenging, and it is rendered based on a combination of clinical, laboratory, histopathologic, immunophenotypic, and molecular findings. The markers most frequently used to identify a TFH immunophenotype in paraffin-embedded tissue sections include PD-1, CXCL13, CXCR5, ICOS, BCL6, and CD10. These neoplasms feature a characteristic and similar, but not identical, mutational landscape with mutations in epigenetic modifiers (TET2, DNMT3A, IDH2), RHOA, and T-cell receptor signaling genes. Here, we briefly review the biology of TFH cells and present a summary of the current pathologic, molecular, and genetic features of nodal lymphomas. We want to highlight the importance of performing a consistent panel of TFH immunostains and mutational studies in TCLs to identify TFH lymphomas.https://www.frontiersin.org/articles/10.3389/fonc.2023.1105651/fullperipheral T cell lymphomasangioimmunoblastic T cell lymphomafollicular T helpernext-generation sequencingmolecular and genetic profiling
spellingShingle Mario L. Marques-Piubelli
Catalina Amador
Francisco Vega
Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
Frontiers in Oncology
peripheral T cell lymphomas
angioimmunoblastic T cell lymphoma
follicular T helper
next-generation sequencing
molecular and genetic profiling
title Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
title_full Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
title_fullStr Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
title_full_unstemmed Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
title_short Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
title_sort pathologic and molecular insights in nodal t follicular helper cell lymphomas
topic peripheral T cell lymphomas
angioimmunoblastic T cell lymphoma
follicular T helper
next-generation sequencing
molecular and genetic profiling
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1105651/full
work_keys_str_mv AT mariolmarquespiubelli pathologicandmolecularinsightsinnodaltfollicularhelpercelllymphomas
AT catalinaamador pathologicandmolecularinsightsinnodaltfollicularhelpercelllymphomas
AT franciscovega pathologicandmolecularinsightsinnodaltfollicularhelpercelllymphomas